Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial

被引:1
|
作者
Kindler, H
Lu, C
Gandara, D
Stevenson, J
Krug, L
Janne, P
Gitlitz, B
Karrison, T
Stadler, W
Vokes, E
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Univ So Calif, Los Angeles, CA USA
关键词
D O I
10.1016/S0169-5002(05)80210-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S28 / S29
页数:2
相关论文
共 50 条
  • [31] Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC)
    Strumberg, Dirk
    Schultheis, Beate
    Ebert, Matthias Philip
    Kerkhoff, A.
    Hofheinz, Ralf Dieter
    Behringer, Dirk M.
    Schmidt, Wolfgang E.
    Goker, Erdem
    De Dosso, Sara
    Kneba, Michael
    Yalcin, Suayib
    Overkamp, Friedrich
    Schlegel, Frank
    Dommach, M.
    Rohrberg, Robert
    Steinmetz, Tilman
    Reuter, Dirk
    Bach, Ferdinand
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Pemetrexed, cisplatin, and bevacizumab in patients with advanced malignant mesothelioma: a multi-center phase II trial
    Dowell, Jonathan E.
    Lan, Cynthia
    Gerber, David
    Hughes, Randall
    Yan Jinsheng
    Xie Yang
    Blake, V
    Taub, Robert
    Dunphy, Frank
    Kindler, Hedy
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S319 - S319
  • [33] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    [J]. Arthritis Research & Therapy, 17
  • [34] Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial
    Jianjun Ou
    Robert C. Smith
    Russell H. Tobe
    Jingjing Lin
    Jen Arriaza
    Jed W. Fahey
    Ruiting Liu
    Ying Zeng
    Yanan Liu
    Lian Huang
    Yidong Shen
    Yamin Li
    Daomeng Cheng
    Brian Cornblatt
    John M. Davis
    Jingping Zhao
    Renrong Wu
    Hua Jin
    [J]. Journal of Autism and Developmental Disorders, 2024, 54 : 628 - 641
  • [35] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [36] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
    Hengge, UR
    Stocks, K
    Wiehler, H
    Faulkner, S
    Esser, S
    Lorenz, C
    Jentzen, W
    Hengge, D
    Goos, M
    Dudley, RE
    Gham, GR
    [J]. AIDS, 2003, 17 (05) : 699 - 710
  • [37] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [38] IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naive Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
    Mitsikostas, Dimos D.
    Dekundy, Andrzej
    Sternberg, Kati
    Althaus, Michael
    Pagan, Fernando
    [J]. ADVANCES IN THERAPY, 2020, 37 (10) : 4249 - 4265
  • [39] Paracervical block in laparoscopic hysterectomy for postoperative pain control: a randomized, multi-center, double-blind, placebo-controlled trial
    Lee, San-Hui
    Kim, Tae-Joong
    Lee, Nae Hyun
    Jeong, Soo Young
    Lee, Jimin
    Song, Taejong
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (03):
  • [40] Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial
    Ou, Jianjun
    Smith, Robert C.
    Tobe, Russell H.
    Lin, Jingjing
    Arriaza, Jen
    Fahey, Jed W.
    Liu, Ruiting
    Zeng, Ying
    Liu, Yanan
    Huang, Lian
    Shen, Yidong
    Li, Yamin
    Cheng, Daomeng
    Cornblatt, Brian
    Davis, John M.
    Zhao, Jingping
    Wu, Renrong
    Jin, Hua
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2024, 54 (02) : 628 - 641